The store will not work correctly when cookies are disabled.
(2Z)-2-{2-[4-(Ethoxycarbonyl)phenyl]hydrazinylidene}-4,4,4-triflouro-3-oxobutanoic acid
ID: ALA4585339
Chembl Id: CHEMBL4585339
PubChem CID: 155567792
Max Phase: Preclinical
Molecular Formula: C13H11F3N2O5
Molecular Weight: 332.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1ccc(N/N=C(\C(=O)O)C(=O)C(F)(F)F)cc1
Standard InChI: InChI=1S/C13H11F3N2O5/c1-2-23-12(22)7-3-5-8(6-4-7)17-18-9(11(20)21)10(19)13(14,15)16/h3-6,17H,2H2,1H3,(H,20,21)/b18-9-
Standard InChI Key: YHQRSLFYWKOZQQ-NVMNQCDNSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.23 | Molecular Weight (Monoisotopic): 332.0620 | AlogP: 1.85 | #Rotatable Bonds: 6 |
Polar Surface Area: 105.06 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: -0.32 | CX Basic pKa: ┄ | CX LogP: 3.96 | CX LogD: -1.01 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.36 | Np Likeness Score: -0.79 |
References
1. Khudina OG, Makhaeva GF, Elkina NA, Boltneva NP, Serebryakova OG, Shchegolkov EV, Rudakova EV, Lushchekina SV, Burgart YV, Bachurin SO, Richardson RJ, Saloutin VI.. (2019) Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers., 29 (23): [PMID:31640885] [10.1016/j.bmcl.2019.126716] |